NO984759D0 - Anvendelse av en osmolytt ved fremstilling av et medikament for behandling av komplikasjoner forÕrsaket av iskemi - Google Patents

Anvendelse av en osmolytt ved fremstilling av et medikament for behandling av komplikasjoner forÕrsaket av iskemi

Info

Publication number
NO984759D0
NO984759D0 NO984759A NO984759A NO984759D0 NO 984759 D0 NO984759 D0 NO 984759D0 NO 984759 A NO984759 A NO 984759A NO 984759 A NO984759 A NO 984759A NO 984759 D0 NO984759 D0 NO 984759D0
Authority
NO
Norway
Prior art keywords
osmolyte
ischemia
medicament
manufacture
treatment
Prior art date
Application number
NO984759A
Other languages
English (en)
Other versions
NO984759L (no
Inventor
Dieter Houssinger
Original Assignee
Dieter Houssinger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dieter Houssinger filed Critical Dieter Houssinger
Publication of NO984759L publication Critical patent/NO984759L/no
Publication of NO984759D0 publication Critical patent/NO984759D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO984759A 1996-04-12 1998-10-12 Anvendelse av en osmolytt ved fremstilling av et medikament for behandling av komplikasjoner forÕrsaket av iskemi NO984759D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9601396A SE9601396D0 (sv) 1996-04-12 1996-04-12 New therapeutic treatment 2
PCT/EP1997/001861 WO1997038685A1 (en) 1996-04-12 1997-04-14 Use of an osmolyte in the preparation of a medicament for treating complications resulting from ischemia

Publications (2)

Publication Number Publication Date
NO984759L NO984759L (no) 1998-10-12
NO984759D0 true NO984759D0 (no) 1998-10-12

Family

ID=20402175

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984759A NO984759D0 (no) 1996-04-12 1998-10-12 Anvendelse av en osmolytt ved fremstilling av et medikament for behandling av komplikasjoner forÕrsaket av iskemi

Country Status (7)

Country Link
EP (1) EP0946167A1 (no)
JP (1) JP2000508651A (no)
AU (1) AU2386097A (no)
CA (1) CA2251071A1 (no)
NO (1) NO984759D0 (no)
SE (1) SE9601396D0 (no)
WO (1) WO1997038685A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
US7608640B2 (en) 1999-03-02 2009-10-27 Jallal Messadek Glycine betaine and its use
BE1012495A3 (fr) 1999-03-02 2000-11-07 Messadek Jallal La glycine-betaine pour son usage antithrombotique.
AU5812800A (en) 1999-06-12 2001-01-02 Stefan Barth Pharmaceutical preparation
ATE283054T1 (de) * 2000-04-12 2004-12-15 Bitop Ag Verwendung von kompatiblen soluten als substanzen mit radikalfangenden eigenschaften
JP5084089B2 (ja) * 2001-06-14 2012-11-28 大塚製薬株式会社 医薬組成物
BE1015608A6 (fr) 2003-07-15 2005-06-07 Messadek Jallal Traitement des arterites.
DE10330768A1 (de) * 2003-07-07 2005-02-24 bitop Aktiengesellschaft für biotechnische Optimierung Verwendung von aus extremophilen Bakterien gewonnenen Osmolyten zur Herstellung von inhalierbaren Arzneimitteln zur Prophylaxe und Behandlung pulmonaler und kardiovaskulärer Erkrankungen, sowie eines Osmolyte als Wirkstoffbestandteil enthaltende Inhalationsvorrichtung
WO2006050581A2 (en) * 2004-11-10 2006-05-18 Jallal Messadek Betaine as agent against arthropod - or mosquito -borne diseases
EP2242489A1 (en) 2005-02-15 2010-10-27 Jallal Messadek Combination therapeutic compositions and method of use
EP1885392B1 (en) 2005-04-27 2012-01-11 Jallal Messadek Insulins combinations
DE102008006780A1 (de) * 2008-01-30 2009-08-06 Bitop Ag Verwendung von Tetrahydropyrimidinen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE464059C (sv) * 1988-09-15 1997-06-02 Perstorp Ab Användning av inositoltrifosfat för framställning av läkemedel
JP2642198B2 (ja) * 1989-08-24 1997-08-20 元庸 村上 胃粘膜障害治療剤
SE8904355D0 (sv) * 1989-12-21 1989-12-21 Perstorp Ab Medicament
WO1991014435A1 (en) * 1990-03-19 1991-10-03 Brigham And Women's Hospital Treatment of osmotic disturbance with organic osmolytes
US5312839A (en) * 1991-03-05 1994-05-17 Regents Of The University Of California Compounds and method for protection of cells and tissues from irreversible injury due to lactic acidosis
BE1007500A3 (fr) * 1992-09-18 1995-07-18 Pasteur Merieux Serums Vacc Solution de perfusion, de conservation et de reperfusion d'organes.
US5582839A (en) * 1995-04-18 1996-12-10 Nutrition 21 Magnesium taurate and other mineral taurates

Also Published As

Publication number Publication date
JP2000508651A (ja) 2000-07-11
WO1997038685A1 (en) 1997-10-23
EP0946167A1 (en) 1999-10-06
NO984759L (no) 1998-10-12
AU2386097A (en) 1997-11-07
CA2251071A1 (en) 1997-10-23
SE9601396D0 (sv) 1996-04-12

Similar Documents

Publication Publication Date Title
NO952573D0 (no) Blandinger for behandling av diabetiske komplikasjoner
EE04390B1 (et) Paikne preparaat dermatoloogiliste seisundite raviks
CY2007001I2 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
HUP9800034A3 (en) Use of propane-1,3-diol derivative for the preparation of a medicament useful for the topical treating of inflammatory and immune diseases
TR199501560A2 (tr) Kademeli olarak saliverilen kafein formülasyonu.
DK0769017T3 (da) Terapeutiske forbindelser
NO20040145L (no) Anvendelse av benzensulfonamidderivater for fremstilling av et medikament
NO984759D0 (no) Anvendelse av en osmolytt ved fremstilling av et medikament for behandling av komplikasjoner forÕrsaket av iskemi
NO995251D0 (no) FremgangsmÕte for administrering av haloterapi
PT777457E (pt) A utilizacao de triacetato de glicerilo para o tratamento de onicomicoses
HK1022269A1 (en) Use of 1-hydroxy-2-pyridones in the manufacture of a medicament for treating skin infections
DK0871438T3 (da) Anvendelse af alfa-hydroxysyrer ved fremstillingen af et medikament til behandling af inflammation
NO20010953D0 (no) En fremgangsmÕte for behandling av stafylokokkal sykdom
NO975660D0 (no) Anvendelse av benzimidazoler for fremstilling av et medikament for behandling av levkemi
GB2319729B (en) A film for topical use in the treatment of wounds
EP0765661A3 (en) Use of docosahexaenoic acid for the manufacture of a medicament for the treatment of glumerulonephritis
EE03384B1 (et) Melatoniini kasutamine ravimi tootmiseks
GB9726343D0 (en) The use of excipients to accelerate freeze-drying
NO982562D0 (no) Sammensetning for behandling av smerte
NO990949D0 (no) Anvendelse av PKC-inhibitorer til fremstilling av et medikament for behandling av AIDS
PT970080E (pt) Derivados de imino-aza-antraciclinona para o tartamento de amiloidoses
LV11966A (lv) Pretiekaisumu lidzeklis arigai lietosanai
NO986053L (no) Anticonvulsivt virkende derivater for anvendelse ved behandling av psoriasis
CA2248753A1 (en) Use of olanzapine for treating excessive aggression
IL117465A (en) Use of certain cystine derivatives for the preparation of a medicament for the treatment of restenosis

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application